Key result
In patients with type 1 diabetes, the severity of autonomic neuropathy was significantly correlated with glucose variability metrics such as Mean Absolute Glucose (ρ=0.62, p<0.01).
Why the study?
Is there an association between cardiovascular autonomic neuropathy and glucose variability in patients with type 1 diabetes?
Cross-Sectional (n=20)
Is there an association between cardiovascular autonomic neuropathy and glucose variability in patients with type 1 diabetes?
In patients with long-standing type 1 diabetes, increased glucose variability is significantly correlated with the severity of cardiovascular autonomic neuropathy.
Association between glucose variability and autonomic neuropathy severity in type 1 diabetes is hypothesis-generating; prospective studies needed to assess causality.
A relationship is suspected between autonomic neuropathy (AN) and glucose variability (GV) as variability is associated with oxidative stress responsible for neuronal damage while the impaired autonomic function has a detrimental effect on metabolism. The oxidative stress associated with glucose variability might be responsible for neuronal damage while autonomic neuropathy has a detrimental effect on metabolism. The aim of the study was to find relationship between AN and GV in type 1 diabetic patients and to identify further factors that affect GV. The aim of the study was to find relationship between AN and GV in type 1 diabetic patients and to determine further factors in the pathogenesis of GV. Patients and methods: 20 type 1 diabetic patients were involved (age: 39.5±3.4 years, duration of diabetes: 17.5±2.5 years; HbA1c: 8.1±0.2%, mean±SE). AN was assessed by the cardiovascular reflex tests (CRT). The interstitial glucose levels were determined following insertion of a subcutaneous electrode during the continuous glucose monitoring (CGM) method on 6 consecutive days. GV was characterized by calculation of 4 parameters. Results: Standard deviation of interstitial glucose values (SD) correlated positively with the overall AN score and the degree of the orthostatic reduction of systolic blood pressure (AN-score-SD ρ=0.47, p<0.05; orthostasis- SD: ρ=0.51, p<0.05). Mean Absolute Glucose: (MAG) correlated with 3 parameters of AN (AN-score-MAG: ρ=0.62, p<0.01; 30/15 ratio-MAG: ρ= -0.50, p<0.05; orthostasis- MAG: ρ=0.59, p<0.01). The HbA1c also correlated with 2 parameters of GV (HbA1c – Continuous Overlapping Net Glycaemic Action [CONGA]: ρ=0.56, p<0.05; HbA1c- MAG: ρ=0.45, p<0.05). The frequency of hypoglycemia did not exhibit any correlation with measures of GV. Conclusions: Severity of glycemic variability but not overall glucose load correlates with both parasympathetic and sympathetic dysfunctions in long-standing type 1 diabetes. Higher HbA1c is associated with more severe glucose variability. The observed correlation between increased glucose variability and the severity of AN necessitates the further exploration of this relationship.
No takes yet. Share an insight, caveat, or question.
Nyiraty et al. (2018) conducted a cross-sectional in Type 1 diabetes (n=20). Autonomic neuropathy was evaluated on Correlation between autonomic neuropathy score and glucose variability (Mean Absolute Glucose) (ρ=0.62, p=<0.01). In patients with type 1 diabetes, the severity of autonomic neuropathy was significantly correlated with glucose variability metrics such as Mean Absolute Glucose (ρ=0.62, p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: